Stock exchange news | Navamedic

Read the latest news directly from the market.

MyControl Support – A brand new support program for patients with obesity

This is a first of its kind in obesity treatment in the Nordic markets with the ambition to offer patients Read more

Navamedic ASA – Registration of share capital increase

Oslo, 7 October 2020: Reference is made to Navamedic ASA's (the "Company") stock exchange announcement published on 30 September 2020 Read more

Navamedic ASA: Mandatory notification of trade

Kathrine Gamborg Andreassen, Chief Executive Officer of Navamedic ASA, has today, on 30 September 2020, exercised 125,000 share options in Read more

NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options

Oslo, 30 September 2020: The board of directors of Navamedic ASA (the "Company"), has today, on 30 September 2020, pursuant Read more

MyControl – A new website to raise awareness about obesity among healthcare professionals and patients

This is the first step in a wave of communication as part of Navamedic’s effort to increase knowledge about obesity, Read more

Navamedic ASA: Q2 and first half 2020 financial results

“In the first half of the year, we took important steps as a pureplay Nordic pharma company targeting growth in Read more

Navamedic ASA: Invitation to 2020 second quarter presentation

Navamedic ASA invites you to a presentation of the 2020 second quarter figures on Thursday August 20th at 08.30 CET. Read more

Navamedic ASA completed the acquisition of marketing authorisations for antibiotics in the Nordics

Oslo, 4 August 2020 – Navamedic ASA (“Navamedic”, OSE: NAVA), today announces it has completed the transaction with ACS Dobfar Read more

Subscribe to stock exhange news